Growth Metrics

Dexcom (DXCM) Net Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -53.07%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.60%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -562.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -283.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -564.44%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 76.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -31.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -394.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 57.36%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn -119.81%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -31.84%
Dec 31, 2025 -23,530.77%
Sep 30, 2025 307.44%
Jun 30, 2025 166.78%
Mar 31, 2025 2.70%
Dec 31, 2024 95.32%
Sep 30, 2024 40.35%
Jun 30, 2024 -84.47%
Mar 31, 2024 1,536.32%
Dec 31, 2023 -33.23%
Sep 30, 2023 -1,725.67%
Jun 30, 2023 2,331.78%
Mar 31, 2023 94.01%
Dec 31, 2022 83.99%
Sep 30, 2022 -110.45%
Jun 30, 2022 -94.44%
Mar 31, 2022 -301.32%
Dec 31, 2021 -373.31%
Sep 30, 2021 101.05%
Jun 30, 2021 868.84%
Mar 31, 2021 -160.14%
Dec 31, 2020 190.26%
Sep 30, 2020 145.73%
Jun 30, 2020 90.40%
Mar 31, 2020 -6.08%
Dec 31, 2019 -93.57%
Sep 30, 2019 -567.51%
Jun 30, 2019 -381.98%
Mar 31, 2019 843.72%
Dec 31, 2018 1,805.97%
Sep 30, 2018 1,612.82%
Jun 30, 2018 -149.01%
Mar 31, 2018 -133.61%
Dec 31, 2017 1,248.57%
Sep 30, 2017 -62.14%
Jun 30, 2017 2,383.67%
Mar 31, 2017 821.95%
Dec 31, 2016 -537.50%
Sep 30, 2016 -41.48%
Jun 30, 2016 -27.41%
Mar 31, 2016 53.41%
Dec 31, 2015 -90.70%
Sep 30, 2015 28.47%
Jun 30, 2015 255.26%
Mar 31, 2015 -804.00%
Dec 31, 2014 -12.24%
Sep 30, 2014 163.46%
Jun 30, 2014 -59.14%
Mar 31, 2014 -76.85%
Dec 31, 2013 196.97%
Sep 30, 2013 533.33%
Jun 30, 2013 1,062.50%
Mar 31, 2013 315.38%
Dec 31, 2012 122.06%
Sep 30, 2012 92.68%
Jun 30, 2012 -97.34%
Mar 31, 2012 347.62%
Dec 31, 2011 -2,058.15%
Sep 30, 2011 -3,063.13%